Should O&P Prepare for Value‑Based Care? A Cost–Benefit Reality Check for Real‑World Practices
Over the last few weeks, I’ve talked about how our so-called “fee-for-service” world already behaves like a bundled, episode-based system and how formal value-based care (VBC) could easily turn into a trap for small O&P practices. That raises a blunt question:
If the future is uncertain, should prosthetists and orthotists invest in outcomes tracking, reputation building, and deeper clinical partnerships now—or sit tight and wait?
A few months ago, you might have had more room to wait and watch. But the environment has changed. CMS and DOJ are putting DMEPOS fraud and abuse on the front page—imposing moratoria, tightening frontend edits, and very publicly going after brace mill behavior. That enforcement push isn’t aimed at honest O&P clinicians, but it absolutely shapes how your practice looks in payer data and how much benefit you get from tightening your own processes.
Let’s walk through a realistic cost–benefit analysis to help you decide what level of change, if any, is worth it so you can protect and grow the practice you’ve already built.
What “preparing for VBC” actually means (in our world)
For a small O&P practice, “getting ready for value-based care” usually boils down to three practical shifts:
Collecting meaningful outcomes data, consistently This is not about building a research institute. It’s about a simple outcomes bundle you can live with day-to-day:
One or two functional measures (AMP/LCItype tool, gait speed, ABC or 6MWT).
Notes that tie device decisions to patient goals and observed results.
Changing how others see prosthetists and orthotists You want to be recognized as an allied health professional who manages function and mobility over an episode, not as “the brace vendor.” That takes:
Clearer communication with physicians, therapists, case managers, and payers that focuses on mobility and safety, not pieces and parts.
A story grounded in data instead of only passion and anecdotes.
Showing up as a clinical partner in episodes of care. That means:
Understanding how your interventions influence mobility, fall-risk reductions, and overall health.
Being ready to talk pathways, goals and outcomes, not just Lcodes and devices.
Those are the core “projects” we’re really talking about. Each has a cost. The key question is whether those costs buy you enough benefit in today’s fraud-sensitive, FFS environment.
The costs: what this asks of a busy practice
1. Time and workflow change
You will need to:
Pick an outcomes set that makes sense for your top patient groups.
Update your practice to use OPIE Anywhere clinical forms, so those measures fit naturally into visits.
Train clinicians and support staff.
There will be a learning curve. You’ll spend some leadership time smoothing rough edges and perfecting the process flow.
2. Leadership and culture energy
You’re asking your team to:
Get comfortable measuring patient progress months after delivery, not just on “device delivered, claim paid.”
Think in terms of episodes (intake through next Rx) instead of deliveries.
That’s not about pressure or perfection. It’s about helping everyone see the bigger picture you’re operating in.
3. Relationship and communication effort (on their terms, not ours)
You will need to be more intentional about how you show up to surgeons, PCPs, rehab, and case managers—but the goal is not more meetings. The goal is to quietly make their lives easier and their metrics better.
Bring very short, very targeted updates: “For your transtibial patients, here’s the one fall statistic and one functional statistic you’ll want in your next quality review.”
Frame everything in their currency: for surgeons, fewer postop complications and smoother discharges; for PCPs, fewer falls, fewer afterhours crises, and patients staying independent; for rehab teams, clearer device plans so therapy time isn’t wasted.
Turn “education” into risk reduction soundbites, not device demonstrations.
Instead of asking for long, non‑billable conversations, you’re slipping outcome snippets and practical suggestions into touchpoints that already exist: discharge calls, quick messages, brief huddle comments, or one strategic lunch a quarter with your highest‑impact referrers.
The mindset shift is: you’re not asking surgeons or PCPs to care about your outcomes program. You’re using your outcomes to help them look good, stay out of trouble, and get their work done with fewer headaches.”
The environment changed: “doing nothing” isn’t neutral anymore
Here’s where the fraud and abuse climate quietly tips your cost–benefit math.
CMS and OIG have made DMEPOS a visible enforcement priority. Recent initiatives include:
A moratorium on certain new DMEPOS suppliers and ramped up screening of existing ones.
Largescale suspensions and denials based on data analytics that look for suspicious billing patterns, especially around orthoses and telemarketing models.
Highly publicized cases where brace mill operations billed millions for medically unnecessary devices without real clinical encounters.
You are not that provider. But when regulators and plans run their algorithms, they don’t start with your intent—they start with your data patterns.
In this environment:
Thin documentation, limited face-to-face notes, and no visible outcomes make you harder to distinguish from the bad actors in a spreadsheet.
Strong documentation and even basic outcomes data make it much easier to show that your pattern of care looks like a real allied health practice, not a product mill.
So the “cost” of doing nothing has gone up. Staying the same isn’t just missing a VBC opportunity; it’s also passing up inexpensive insurance against being misunderstood in a fraud sensitive system.
The benefits: why these moves help you even if VBC never shows up
The good news is that the same changes buy you several kinds of protection and growth.
1. Better clinical insight and sharper decisions
Collecting a small set of outcomes lets you see patterns you can’t see in your head:
Which devices and approaches are working best with your specific population.
Where complications, returns, or disappointing outcomes seem to cluster.
How different referral sources or comanaging clinicians affect trajectories.pubmed.ncbi.nlm.nih+1
You can use that insight to:
Refine your own clinical decision making.
Standardize what works across your team.
Bring hard data into conversations with surgeons and PT/OT: “Here’s what we’re consistently seeing in your patients over 6–12 months.”pubmed.ncbi.nlm.nih+1
That’s valuable whether or not any payer ever says “value-based” to you.
2. Stronger professional identity and differentiation
On paper, Medicare still places O&P under the DMEPOS benefit with fee schedules. From far away, it’s easy for a plan or system to see you as “fancy DME.”cms+1
When you combine:
Clearly documented, face-to-face evaluation and follow-up.
Outcomes that show you’re managing function and risk over time.
A willingness to talk in episode and total cost terms,
you start to match the profile of an allied health professional managing a complex, long term clinical intervention, not a parts vendor.cms+1
That makes you much harder to replace with “cheaper braces” or generalist management when finance leaders start asking tough questions.
3. A better shield in a fraud focused world
In a climate where CMS is actively hunting abusive patterns in DMEPOS, good documentation and outcomes become part of your compliance shield.
What you want your data to show:
Appropriate patients, seen and followed by real clinicians.
Device choices tied to documented medical need and functional goals.
Results that line up with what the broader O&P evidence suggests (e.g., better function, fewer facility days, different post acute patterns).opiesoftware+3
You can’t guarantee you’ll never get questions. But you can make it far easier to answer those questions confidently.
Cost–benefit, in plain language
Summing it up:
You invest:
Time and some money to build simple, sustainable outcomes workflows.
Leadership energy to help your team think in episodes and accept being measured.
Relationship effort to tell your story to the rest of the care team and, when appropriate, to plans or systems.
You gain:
Better insight into your own clinical and business performance.
A stronger, more defensible identity as an allied health provider instead of a parts vendor.
A clearer, data backed distinction from the DMEPOS fraud stories driving today’s enforcement climate.
A running start if and when formal VBC models reach your patients.chartspan+2
From my perspective, that math favors thoughtful, incremental change—not a radical reinvention, but intentional steps toward being the O&P partner your local system needs when it’s under pressure to prove value and stay out of the headlines.
You’re not chasing buzzwords. You’re futureproofing the work you already believe in, in a way that supports your clinicians, your patients, and the long-term health of your practice.
In the next posts, we’ll look at common innovation mistakes leaders make—things like piling “transformation” on top of already full plates, chasing tools without clear goals, or under communicating change—and translate those into practical do’s and don’ts for O&P practices that want to evolve without burning out. fastcompany
If this cost–benefit pass did its job, you’re not asking, “Should we change?” anymore. You’re asking, “How do we change in a way that fits our size, our people, and our patients?”
